Investment Banking interview preparation
Every question below is either traced to a named firm from a public candidate report, or tagged at desk level when we could not trace it. Answers are written the way you would actually say them out loud — answer first, then the mechanism, then the limitation.
100 questions, mapped to the firms that asked them
- Questions
- 100
- Traced to a firm
- 100
- Firms
- 46
- Updated
- September 2026
007What are some non-cash items you would find on the cash flow statement?Moody'sProject Finance · New York · 2018LazardInvestment Banking · New York · 2026
Say this
Depreciation and amortisation, stock-based compensation, deferred taxes, impairments and write-downs, unrealised gains or losses on investments, and equity income from unconsolidated affiliates.
Then walk it
- D&A is the big one and the one everyone names.
- Stock-based compensation is the one that matters most in practice, especially in tech, because it is a real cost to shareholders that never touches cash.
- Deferred tax movements, impairments and goodwill write-downs are all added back.
- Equity method income gets reversed out and replaced with the actual dividend received, because you only book cash you were paid.
- The judgement call is SBC. Adding it back and calling the result free cash flow overstates what shareholders actually keep, because the dilution is real.
Where candidates lose it
Listing D&A and stopping. Naming stock-based compensation, and then saying why treating it as a pure add-back is dishonest, is what separates a memoriser from someone who has actually thought about earnings quality.
Expect next
- Should stock-based compensation be added back in a DCF?
- How do you handle it when you are comparing a tech company to an industrial?
- What is the difference between deferred tax assets and liabilities?
Reported by candidates at Moody's (Project Finance, New York, 2018); Lazard (Investment Banking, New York, 2026). Source: Wall Street Oasis.
039Would an increase in price or an increase in volume be more preferable when you are trying to deliver synergies?LazardMergers and Acquisitions · New York · 2026
Say this
Price, almost always. A price increase drops straight to the bottom line with no incremental cost, while a volume increase carries variable cost, working capital and often capacity investment with it.
Then walk it
- A dollar of price is a dollar of gross profit. A dollar of volume is a dollar times the gross margin, so at a 40 percent margin you need two and a half times the revenue to get the same profit.
- Volume also consumes cash. More units means more inventory and receivables, and eventually more capacity, so free cash flow lags the revenue.
- Price is also faster. You can reprice a portfolio in a quarter; winning share takes years.
- The counterargument, and I would raise it: price synergies are much harder to defend to regulators, because raising prices post-merger is precisely what antitrust authorities are watching for. Volume and cost synergies are safer ground in a filing.
- Price is also fragile. It invites competitive response and it can accelerate customer churn, so the durability is lower even though the immediate flow-through is better.
Where candidates lose it
Answering only with the margin arithmetic. The regulatory dimension is what makes this an M&A question rather than a maths question, and at a firm like Lazard that is the half they are listening for.
Expect next
- How would you defend price synergies to a regulator?
- Which synergies do you actually put in the model?
- Why do most deals miss their synergy targets?
Reported by candidates at Lazard (Mergers and Acquisitions, New York, 2026). Source: Wall Street Oasis.
051Walk me through an LBO.Truist SecuritiesGeneralist · Charlotte · 2024TPGInvestment Banking · New York · 2024Advent InternationalTechnology, Media and Telecom · Palo Alto · 2020LazardInvestment Banking · New York · 2026
Say this
Buy a company using mostly debt, use its own cash flow to pay that debt down over five years, then sell it. The equity return comes from deleveraging, from growing EBITDA, and from any multiple expansion.
Then walk it
- Set the entry: purchase price as a multiple of EBITDA, then a sources and uses table. Debt takes you as far as the credit market allows, say five times EBITDA, and the sponsor writes a cheque for the rest plus fees.
- Project the operating model for five years, then build the debt schedule: interest, mandatory amortisation, and a cash sweep that applies surplus cash to the debt.
- Free cash flow after interest pays down debt each year, so the equity slice grows even if enterprise value does not move at all. That is deleveraging.
- Exit at an assumed multiple on final-year EBITDA, subtract the remaining debt, and you have exit equity value.
- Compute IRR and money multiple against the initial cheque. Then attribute the return across the three drivers: debt paydown, EBITDA growth and multiple change. A sponsor will always ask which one is carrying the deal.
- The sanity test: if the whole return depends on exiting at a higher multiple than you paid, it is not an investment thesis, it is a bet on the market.
Where candidates lose it
Describing the mechanics with no attribution of returns. Every good LBO answer ends with which of the three drivers produces the IRR, and an acknowledgement that multiple expansion is the one you cannot control.
Expect next
- How do you drive returns in an LBO?
- What makes a good LBO candidate?
- Do a paper LBO for me.
Reported by candidates at Truist Securities (Generalist, Charlotte, 2024); TPG (Investment Banking, New York, 2024); Advent International (Technology, Media and Telecom, Palo Alto, 2020); Lazard (Investment Banking, New York, 2026). Source: Wall Street Oasis.
059Why would a sponsor prefer to take on high yield debt to finance an LBO rather than bank debt?LazardGeneralist · Amsterdam · 2025
Say this
Flexibility. High yield bonds are typically fixed rate, bullet maturity, with no maintenance covenants and no mandatory amortisation. You pay more in coupon to buy freedom and certainty of cash flow.
Then walk it
- No amortisation. Bank term loans grind down cash with mandatory repayments and a cash sweep; bonds are bullet, so all the cash stays in the business for growth or bolt-ons.
- Covenant-light. Bonds carry incurrence covenants that only bite when you do something, rather than maintenance covenants tested every quarter. A sponsor running a turnaround does not want a quarterly leverage test.
- Fixed rate. Bonds lock the coupon, so a rising rate environment does not eat the equity. Floating-rate term loans expose the deal to rate risk unless hedged.
- Longer tenor, usually seven to ten years against five to seven for a term loan, so no refinancing wall mid-hold.
- The costs, which you should name: a higher coupon, call protection that makes early repayment expensive, and a public disclosure burden. So the real answer is that sponsors use both, bank debt for the cheap senior layer and bonds for the flexible layer, and the mix depends on whether the thesis needs cash flexibility or the lowest possible cost.
Where candidates lose it
Answering 'because banks will not lend that much'. Sometimes true, but it misses the point. The trade is cost against flexibility, and naming covenant structure and bullet maturity is what shows leveraged finance literacy.
Expect next
- What is the difference between incurrence and maintenance covenants?
- Describe the differences between private credit and bank syndicated debt.
- What is call protection?
Reported by candidates at Lazard (Generalist, Amsterdam, 2025). Source: Wall Street Oasis.
Firm tags come from public, anonymous candidate reports on Wall Street Oasis: strong signal, not sworn testimony. Firms are named as the places a question was reported, not as partners of Fin Maverick. Answers are written for this page to show how to think out loud; they are not scripts to recite.
